The drugs that are given that are directly toxic to cancer cells.

The group of patients in a clinical trial that receive standard of care treatment.

The process a patient undergoes of learning the key facts about a clinical trial before deciding whether or not to participate.

The type of cancer treatment that uses electromagnetic waves to penetrate the body and eliminate cancer cells.

The phase of clinical trials that assesses the safety of a new treatment modality.

The doctor who treats the patient during a clinical trial, who works with the research team to monitor the patient closely.

The type of treatment that involves the removal of cancer tissue.

The extensive supporting information required for a drug to reach clinical trials.

The study plan on which a clinical trial is based that is carefully designed and reviewed by administrators and researchers to ensure the safety of the patient.

The physician who analyzes images taken of the body to understand the state of the cancer.

The suspension of an arm of a clinical trial due to the overwhelming benefit observed in the other arm.

The board that critically evaluates all clinical trials proposals for ethical considerations and assesses whether the benefit accrued from a trial will outweigh the harm.The group of patients in a clinical trial that receive the new treatment modality being assessed.

The removal of tissue from the body that is performed to assess whether cancer is present.

The group of patients in a clinical trial that receive the new treatment modality being assessed.